Trial Profile
Phase 2 higher-dose study of S-888711 in thrombocytopenic patients with chronic liver disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2018
Price :
$35
*
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 25 Mar 2015 New trial record